首页> 外文会议>American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics >Proteomics of Alzheimer's disease: Candidate proteins identified in serum as diagnostic biomarker for Alzheimer's disease
【24h】

Proteomics of Alzheimer's disease: Candidate proteins identified in serum as diagnostic biomarker for Alzheimer's disease

机译:阿尔茨海默病的蛋白质组学:血清中鉴定的候选蛋白,作为阿尔茨海默病的诊断生物标志物

获取原文

摘要

Alzheimer's disease(AD) is the most common cause of dementia of late life. To enhance our understanding of AD proteome, the serum proteins were analyzed using two-dimensional gel electrophoresis combined with nano-high performance liquid chromatography electrospray ionization tandem mass spectrometry followed by peptide fragmentation patterning. In this study, six protein spots with differential expression were identified. Five up-regulated proteins were identified asactin, apolipoproteinA-IV, inter-alpha-trypsin inhibitor heavy chain H4, alpha-1-antitrypsin, andantithrombin-III; one protein, activity-dependentneuroprotector homeoboxprotein (ADNP) was down-regulated in AD patients. These proteins with differential expression in theserum may serve as potential indicators of AD. Our results suggested that ADNP may play an important role in slowing the progression of clinical symptoms of AD.
机译:阿尔茨海默病(AD)是晚期痴呆症的最常见原因。为了增强我们对Ad蛋白质组的理解,使用二维凝胶电泳分析血清蛋白质,与纳米高性能液相色谱电泳电镀电离电离串联质谱分析,然后用肽碎片图案化。在该研究中,鉴定了六种具有差异表达的六种蛋白质斑点。鉴定了五种上调的蛋白质,透氧蛋白,载脂蛋白-IV,α-胰蛋白酶间抑制剂重链H4,Alpha-1-Anti rrypsin,Andantithrombin-III;一种蛋白质,活性依赖性urboRotector Homeoboxprotein(ADNP)在AD患者中受到下调。具有差异表达的这些蛋白质可以作为广告的潜在指标。我们的结果表明,ADNP可能在减缓广告的临床症状进展方面发挥着重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号